Bioanalytical approaches to analyzing peptides and proteins by LC-MS/MS

Bioanalysis

Volumn 3, Issue 12, 2011, Pages 1379-1397

  Ewles, Matthew ^a   Goodwin, Lee ^a  

^a UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; APROTININ; ASCORBIC ACID; BESTATIN; CHLORAMPHENICOL; CYSTEINE; DITHIOTHREITOL; DYFLOS; EDETIC ACID; FLUORIDE SODIUM; GLUTATHIONE; HYDROCHLORIC ACID; IMMUNOGLOBULIN; MERCAPTOETHANOL; PEPTIDE; PESTATIN A; PHENYLMETHYLSULPHONYL FLUORIDE; PROTEIN; PROTEINASE INHIBITOR; SODIUM AZIDE; STREPTOMYCIN; TRYPSIN; UNCLASSIFIED DRUG;

ACCURACY; ADSORPTION; ANTIBODY AFFINITY; ANTIGEN PURIFICATION; CALIBRATION; DRUG ACTIVITY; DRUG STABILITY; HIGH THROUGHPUT SCREENING; HUMAN; HYDROPHILICITY; IMMUNOASSAY; INTERMETHOD COMPARISON; ISOELECTRIC POINT; LIQUID CHROMATOGRAPHY; MOLECULAR STABILITY; MOLECULAR WEIGHT; PEPTIDE ANALYSIS; PH; PRECIPITATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; SOLUBILITY; STANDARD; TANDEM MASS SPECTROMETRY;

ADSORPTION; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; HUMANS; IMMUNOASSAY; PEPTIDES; PHARMACEUTICAL PREPARATIONS; PROTEINS; REFERENCE STANDARDS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TRYPSIN;

EID: 79959485825     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.112     Document Type: Review

References (71)

1. Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M. Synthetic therapeutic peptides: science and market. Drug Discovery Today 15, 40-56 (2010).
2. Peptide Therapeutics Foundation; Reichert J, Pechon P, Tartar A, Dunn MK. Development trends for peptide therapeutics: a comprehensive quantitative analysis of peptide therapeutics in clinical development (report summary). (2010).
3. Borghouts C, Kunz C, Groner B. Current strategies for the development of peptide-based anti-cancer therapeutics. J. Peptide Sci. 11, 713-726 (2005). (Pubitemid 41684258)
4. Pichereau C, Allary C. Therapeutic peptides under the spotlight. Eur. BioPharm. Rev. Winter issue, 88-91 (2005).
5. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for Industry: Bioanalytical Method Validations (2001).
6. Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J. Immunol. Meth. 347, 3-11 (2009).
7. John H, Walden M, Schäfer S, Genz S, Forssmann W. Analytical procedures for quantification of peptides in pharmaceutical research by liquid chromatography-mass spectrometry. Anal. Bioanal. Chem. 378, 883-897 (2004). (Pubitemid 40890201)
8. Tamvakopoulos C. Mass spectrometry for the quantification of bioactive peptides in biological fluids. Mass Spectrom. Rev. 26, 389-402 (2007). (Pubitemid 46750376)
9. van den Broek I, Sparidans RW, Schellens JHM, Beijnen JH. Quantitative bioanalysis of peptides by liquid chromatography coupled to tandem mass spectrometry. J. Chromatogr. B 872, 1-22 (2008).
10. van Midwoud PM, Rieux L, Bischoff R, Verpoorte E, Niederländer HAG. Improvement of recovery and repeatability in liquid chromatography-mass spectrometry analysis of peptides. J. Proteome Res. 6, 781-791 (2007). (Pubitemid 46340181)
11. Grohganz H, Rischer M, Brandl M. Adsorption of the decapeptide Cetrorelix depends both on the composition of dissolution medium and the type of solid surface. Eur. J. Pharm. Sci. 21, 191-196 (2004). (Pubitemid 38156156)
12. van Platerink CJ, Janssen HM, Horsten R, Haverkamp J. Quantification of ACE inhibiting peptides in human plasma using high performance liquid chromatography- mass spectrometry. J. Chromatogr. B 830, 151-157 (2006). (Pubitemid 41831401)
13. Reubsaet JLE, Beijnen JH, Bult A, van Maanen RJ, Daniëlle Marchal JA, Underberg WJM. Analytical techniques used to study the degradation of proteins and peptides: chemical instability. J. Pharm. Biomed. Anal. 17, 955-978 (1998). (Pubitemid 29023074)
14. Wolf R, Rosche F, Hoffmann T, Demuth HU. Immunoprecipitation and liquid chromatography-mass spectrometric determination of the peptide glucose-dependent insulinotropic polypeptides GIP1-42 and GIP3-42 from human plasma samples. New sensitive method to analyze physiological concentrations of peptide hormones. J. Chromatogr. A 926, 21-27 (2001). (Pubitemid 32739003)
15. Fanciulli G, Azara E, Wood TD, Delitala G, Marchetti M. Liquid chromatography-mass spectrometry assay for quantification of gluten exorphin B5 in cerebrospinal fluid. J. Chromatogr. B 852, 485-490 (2007). (Pubitemid 46830147)
16. Addison TE, King MJ, Larson MJ. Investigation of conditions necessary to stabilize a polypeptide therapeutic in plasma to support early drug development and analysis by LC-MS/MS. Poster presented at: 8th Annual Land O?Lakes Bioanalytical Conference. Merrimac, WI, USA, 9-13 July 2007.
17. Li W, Tse LS. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed. Chromatogr. 24, 49-65 (2010).
18. Alfazil AA, Anderson RA. Stability of benzodiazepines and cocaine in blood spots stored on filter paper. J. Anal. Toxicol. 32, 511-515 (2008).
19. Kehler JR, Bowen CL, Boram SL, Evans CA. Application of DBS for quantitative assessment of the peptide exendin-4; comparison of plasma and DBS method by UHPLC-MS/MS. Bioanalysis 2, 1461-1468 (2010).
20. Ewles MF, Turpin PE, Goodwin L, Bakes DM. Validation of a bioanalytical method for the quantification of a therapeutic peptide, ramoplanin, in human dried blood spots using LC-MS/MS. Biomed. Chromatogr. DOI: 10.1002/bmc.1555 (2010) (Epub ahead of print).
21. Hu X, Kamberi M. Quantification of apolipoprotein A-I mimetic peptide D-4F in rabbit plasma by high-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry. J. Chromatogr. B 877, 1946-1950 (2009).
22. Chang D, Kolis SJ, Linderholm KH, et al. Bioanalytical method development and validation for a large peptide HIV fusion inhibitor (Enfuvirtide, T-20) and its metabolite in human plasma using LC-MS/MS. J. Pharm. Anal. 38, 487-496 (2005). (Pubitemid 40733186)
23. Han B, Copeland M, Geiser AG, et al. Development of a highly sensitive, high throughput, mass spectrometry-based assay for rat procollagen type-1 N-terminal propeptide (P1NP) to measure bone formation activity. J. Proteome Res. 6, 4218-4229 (2007). (Pubitemid 350158500)
24. Polson C, Sarkar P, Incledon B, Raguvaran V, Grant R. Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 785, 263-275 (2003). (Pubitemid 36126166)
25. Becher F, Pruvost A, Clement G, Tabet JC, Ezan E. Quantification of small therapeutic proteins in plasma by liquid chromatography-tandem mass spectrometry: applications to an elastase inhibitor EPI-hNE4. Anal. Chem. 78, 2306-2313 (2006).
26. Gorman GS, Coward LU, Freeman L, Noker PE, Beattie CW, Jia L. A novel and rapid LC-MS/MS assay for bioanalysis of azurin p28 in serum and its pharmacokinetics in mice. J. Pharm. Biomed. Anal. 53, 991-996 (2010).
27. Cheng C, Liu S, Xiao D, et al. LC-MS/MS method development and validation for the determination of polymyxins and vancomycin in rat plasma. J. Chromatogr. B 878, 2831-2838 (2010).
28. Pan G, Wang X, Huang Y, Gao X, Wang Y. Development and validation of a LC-MS/MS method for determination of bivalirudin in human plasma: application to a clinical pharmacokinetic study. J. Pharm. Biomed. Anal. 52, 105-109 (2010).
29. Wilson SF, Li H, Rose MJ, Xiao J, Holder JR, James CA. Development and validation of a method for the determination of a therapeutic peptide with affinity for the human B1 receptor in human plasma using HPLC-MS/MS. J. Chromatogr. B 878, 749-757 (2010).
30. Li H, Rose MJ, Tran L, et al. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. J. Pharm. Toxicol. Meth. 59, 171-180 (2009).
31. Kim MK, Lee TH, Suh JH, et al. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of goserelin in rabbit plasma. J. Chromatogr. B 878, 2235-2242 (2010).
32. Aristoteli LP, Molloy MP, Baker MS. Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery. J. Proteome Res. 6, 571-581 (2007). (Pubitemid 46340161)
33. Ji QC, Rodila R, El-Shourbagy TA. A sample preparation process for LC-MS/MS analysis of total protein drug concentrations in monkey plasma samples with antibody. J. Chromatogr. B 847, 133-141 (2007). (Pubitemid 46331015)
34. Herraiz T, Casal V. Evaluation of solid-phase extraction procedures in peptide analysis. J. Chromatogr. A 708, 209-221 (1995).
35. Siskos AP, Katsila T, Balafas E, Kostomitsopoulos N, Tamvakopoulos C. Simultaneous absolute quantification of the glucose-dependent insulinotropic polypeptides GIP1-42 and GIP3-42 in mouse plasma by LC-ESI-MS/MS: preclinical evaluation of DP-IV inhibitors. J. Proteome Res. 8, 3487-3496 (2009).
36. Ewles MF, Goodwin L, Bakes D. Feasibility assessment of a bioanalytical method for quantification of a 14.3 kDa protein in human plasma using tryptic digestion LC-MS/MS without a requirement for antibodies. Chromatogr. Today 3, 26-29 (2010).
37. Bondar OP, Barnidge DR, Klee EW, Davis BJ, Klee GG. LC-MS/MS quantification of a Zn-a2 glycoprotein: a potential serum biomarker for prostate cancer. Clin. Chem. 53, 673-678 (2007). (Pubitemid 46580237)
38. Buscher BAP, Gerritsen H, van Schöll I, Cnubben NHP, Brüll LP. Quantitative analysis of tenecteplase in rat plasma using LC-MS/MS as an alternative for ELISA. J. Chromatogr. B 852, 631-634 (2007). (Pubitemid 46830103)
39. deWilde A, Sadilkova K, Sadilek M, Vasta V, Hahn SH. Tryptic peptide analysis of ceruloplasmin in dried blood spots using liquid chromatography- tandem mass spectrometry: application to newborn screening. Clin. Chem. 54, 1961-1968 (2008). (Pubitemid 352774028)
40. Berna MJ, Zhen Y, Watson DE, Hale JE, Ackermann BL. Strategic use of immunoprecipitation and LC-MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis. Anal. Chem. 79, 4199-4205 (2007). (Pubitemid 46903173)
41. van den Broek I, Sparidans RW, Schellens JHM, Beijnen JH. Enzymatic digestion as a tool for the LC-MS/MS quantification of large peptides in biological matrices: measurements of chymotryptic fragments from the HIV-1 fusion inhibitor enfuvirtide and its metabolite M-20 in human plasma. J. Chromatogr. B 854, 245-259 (2007). (Pubitemid 46970742)
42. Yang Z, Ke J, Hayes M, Bryant M, Tse FLS. A sensitive and high-throughput LC-MS/MS method for the quantification of pegylated-interferon a2a in human serum using monolithic C18 SPE for enrichment. J. Chromatogr. B 877, 1737-1742 (2009).
43. Winther B, Moi P, Nordlund MS, Lunder N, Paus E, Reubsaet JLE. Absolute ProGRP quantification in a clinical relevant concentration range using LC-MS/MS and a comprehensive internal standard. J. Chromatogr. B 877, 1359-1365 (2009).
44. Ramström M, Hagman C, Mitchell JK, Derrick PJ, Håkansson P, Bergquist J. Depletion of high-abundant proteins in body fluids prior to liquid chromatography fourier transform ion cyclotron resonance mass spectrometry. J. Proteome Res. 4, 410-416 (2005). (Pubitemid 40548146)
45. Whiteaker JR, Zhao L, Zhang HY, et al. Antibody-based enrichment of peptides on magnetic beads for mass spectrometry-based quantification of serum biomarkers. Anal. Biochem. 362, 44-54 (2007). (Pubitemid 46198803)
46. Hoofnagle AN, Becker JO, Wener MH, Heinecke JW. Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin. Chem. 54, 1796-1804 (2008).
47. Li F, Schmerberg CM, Ji QC. Accelerated tryptic digestion of proteins in plasma for absolute quantitation using a protein internal standard by liquid chromatography-tandem mass spectrometry. Rapid Commun. Mass Spectrom. 23, 729-732 (2009).
48. Pramanik BN, Mirza UA, Ing YH, et al. Microwave-enhanced enzyme reaction for protein mapping by mass spectrometry: a new approach to protein digestion in minutes. Protein Sci. 11, 2676-2687 (2002). (Pubitemid 35191141)
49. Lesur A, Varesio E, Hopfgartner G. Accelerated tryptic digestion for the analysis of biopharmaceutical monoclonal antibodies in plasma by liquid chromatography with tandem mass spectrometric detection. J. Chromatogr A 1217, 57-64 (2010).
50. Durfield DR, Nemirovskiy OV, Jennings MG, Tortorella MD, Malfait AM, Mathews WR. An immunoaffinity liquid chromatography-tandem mass spectrometry assay for detection of endogenous aggrecan fragments in biological fluids: use as a biomarker for aggrecanase activity and cartilage degradation. Anal. Biochem. 406, 113-123 (2010).
51. Mant CT, Lorne Burke TW, Hodges RS. Optimization of peptide separations in reversed-phase HPLC: isocratic versus gradient elution. Chromatographia 24, 565-572 (1987).
52. Giorgianni F, Cappiello A, Beranova- Giorgianni S, Palma P, Trufelli H, Desiderio DM. LC-MS/MS analysis of peptides with methanol as organic modifier: improved limits of detection. Anal. Chem. 76, 7028-7038 (2004). (Pubitemid 39600877)
53. Garcia MC. The effect of the mobile phase additives on sensitivity in the analysis of peptides and proteins by high-performance liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B 825, 111-123 (2005). (Pubitemid 41423594)
54. Apffel A, Fischer S, Goldberg G, Goodley PC, Kuhlmann FE. Enhanced sensitivity for peptide mapping with electrospray liquid chromatography-mass spectrometry in the presence of signal suppression due to trifluoroacetic acid-containing mobile phases. J. Chromatogr. A 712, 177-190 (1995).
55. Toll H, Oberacher H, Swart R, Huber CG. Separation, detection, and identification of peptides by ion-pair reversed-phase high-performance liquid chromatography- electrospray ionization mass spectrometry at high and low pH. J. Chromatogr. A 1079, 274-286 (2005). (Pubitemid 40813209)
56. Zhu B, Mant CT, Hodges RS. Mixed-mode hydrophilic and ionic interaction chromatography rivals reversed-phase liquid chromatography for the separation of peptides. J. Chromatogr. 594, 75-86 (1992).
57. Yoshida T. Peptide separation by hydrophilic interaction chromatography: a review. J. Biochem. Biophys. Meth. 60, 265-280 (2004). (Pubitemid 39179382)
58. Jian W, Edom RW, Xu Y, Weng N. Recent advances in application of hydrophilic interaction chromatography for quantitative bioanalysis. J. Separation Sci. 33, 681-697 (2010).
59. Bedani F, Janssen H-G. Using two-dimensional liquid chromatography to separate complex mixtures of peptides. LC GC Europe 22, 248-255 (2009).
60. Lövgren U, Johansson S, Jensen LS, Ekström C, Carlshaf A. Quantitative determination of peptide drug in human plasma samples at low pg/ml levels using coupled column liquid-chromatography-tandem mass spectrometry. J. Pharma. Biomed. Anal. 53, 537-545 (2010).
61. Heinig K, Wirz T, Yuan M, Tingler M, Mylott W. An improved LC-MS/MS method for the determination of taspoglutide in plasma and urine using orthogonal HILIC-RP column switching, ultra-performance LC separation and ?wrong-way-round? electrospray ionisation. Biomed. Chromatogr. DOI: 10.1002/bmc.1593 (2011) (Epub ahead of print).
62. Liu A, Tweed J, Wujcik CE. Investigation of an on-line two-dimensional chromatographic approach for peptide analysis in plasma by LC-MS/MS. J. Chromatogr. B 877, 1873-1881 (2009).
63. Dai S, Song H, Dou G, et al. Quantification of sifuvirtide in monkey plasma by an on-line solid-phase extraction procedure combined with liquid chromatography-electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 19, 1273-1282 (2005). (Pubitemid 40728141)
64. Wang Q, Xiang S, Jia Y, et al. An improved on-line SPE coupled HPLC-MS/MS system for quantification of sifuvirtide in human plasma. J. Chromatogr. B 878, 1893-1898 (2010).
65. Wilm M, Mann M. Analytical properties of the nanoelectrospray ion source. Anal. Chem. 68, 1-8 (1996).
66. Oosterkamp AJ, Gelpi E, Abian J. Quantitative peptide bioanalysis using column-switching nano liquid chromatography-mass spectrometry. J. Mass Spectrom. 33, 976-983 (1998). (Pubitemid 28499665)
67. Sinnaeve BA, Van Bocxlaer JF. Evaluation of nano-liquid chromatography-tandem mass spectrometry in a column switching setup for the absolute quantification of peptides in the picomolar range. J. Chromatogr. A 1058, 113-119 (2004). (Pubitemid 39487210)
68. Lortie M, Bark S, Blantz R, Hook V. Detecting low-abundance vasoactive peptides in plasma: progress toward absolute quantitation using nano liquid chromatography-mass spectrometry. Anal. Biochem. 394, 164-170 (2009).
69. Tuthill CW, Rudolph A, Li Y, et al. Quantitative analysis of thymosin α1 in human serum by LC-MS/MS. AAPS PharmSciTech 1(2), article 11 (2000).
70. Klaassen T, Szwandt S, Kapron JT, Roemer A. Validated quantitation method for a peptide in rat serum using liquid chromatography/high-field asymmetric waveform ion mobility spectrometry. Rapid Commun. Mass Spectrom. 23, 2301-2306 (2009).
71. Xia YQ, Wu ST, Jemal M. LC-FAIMS- MS/MS for quantification of a peptide in plasma and evaluation of FAIMS global selectivity from plasma components. Anal. Chem. 80, 7137-7143 (2008).